United States Pharmaceuticals

OSI Pharmaceuticals LLC (OSIP)

Track

Stock chart
Ticker: OSIP
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Astellas Pharma Inc.
1 purchase — total 367,269,463 USD
Buy 7 Jun 2010
Value US$4,384,125.64 | Price 273.72 | Shares 89,345
Buy 4 Jun 2010
Value US$1,476,235.88 | Price 334.44 | Shares 92,131
Planned sale 1 Mar 2010
Value US$1,611,840.00 | Price 55.20 | Shares 29,200
Planned sale 1 Mar 2010
Value US$1,102,200.00 | Price 55.11 | Shares 20,000
Planned sale 1 Mar 2010
Value US$875,968.80 | Price 55.20 | Shares 15,869
Planned sale 1 Mar 2010
Value US$3,641,220.00 | Price 55.17 | Shares 66,000
Planned sale 1 Mar 2010
Value US$2,393,811.21 | Price 55.37 | Shares 43,233
Planned sale 3 Feb 2009
Value US$82,500.00 | Price 41.25 | Shares 2,000
Planned sale 3 Feb 2009
Value US$140,291.25 | Price 41.25 | Shares 3,401
Planned sale 3 Feb 2009
Value US$420,954.00 | Price 42.10 | Shares 10,000
Planned sale 6 Jan 2009
Value US$1,960.00 | Price 40.00 | Shares 49
Sale 19 Nov 2008
Value US$391,100.00 | Price 39.11 | Shares 10,000
Sale 11 Nov 2008
Value US$138,355.00 | Price 39.53 | Shares 3,500
Planned sale 7 Nov 2008
Value US$47,828.50 | Price 41.59 | Shares 1,150
Planned sale 1 Oct 2008
Value US$121,750.00 | Price 48.70 | Shares 2,500
Planned sale 1 Oct 2008
Value US$56,005.00 | Price 48.70 | Shares 1,150
Planned sale 15 Sep 2008
Value US$86,747.50 | Price 49.57 | Shares 1,750
Planned sale 2 Sep 2008
Value US$189,075.00 | Price 50.42 | Shares 3,750
Planned sale 2 Sep 2008
Value US$57,983.00 | Price 50.42 | Shares 1,150
Planned sale 15 Aug 2008
Value US$39,622.50 | Price 52.83 | Shares 750
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2010-06-09 2010-06-07 B Purchase Astellas Pharma Inc. Large shareholder
89,345 -8.7%
273.72
US$4,384,126 		89,345 -8.7% 273.72 US$4,384,126
2010-06-08 2010-06-04 B Purchase Astellas Pharma Inc. Large shareholder
92,131 +13.1%
334.44
US$1,476,236 		92,131 +13.1% 334.44 US$1,476,236
2010-03-03 2010-03-01 PlS Planned sale LUNDEMOSE ANKER MD, PH.D, DSC

EVP, Corp. Dev & Strategic Pln

Officer
99,041 +10.0%
226.14
US$2,041,016 		99,041 +10.0% 226.14 US$2,041,016
2010-03-03 2010-03-01 PlS Planned sale WOOD BARBARA A

Sr. V.P. & General Counsel

Officer
20,000 -42.2%
55.11
US$1,102,200 		20,000 -42.2% 55.11 US$1,102,200
2010-03-03 2010-03-01 PlS Planned sale AMPER LINDA E

Sr. VP, Human Resources

Officer
15,869 -45.4%
55.20
US$875,969 		15,869 -45.4% 55.20 US$875,969
2010-03-03 2010-03-01 PlS Planned sale GODDARD COLIN

Chief Executive Officer

Executive Director
66,000 -29.4%
55.17
US$3,641,220 		66,000 -29.4% 55.17 US$3,641,220
2010-03-03 2010-03-01 PlS Planned sale LEUNG GABRIEL

EVP & Pres. Pharma. Business

Officer
43,233 -53.0%
55.37
US$2,393,811 		43,233 -53.0% 55.37 US$2,393,811
2009-02-05 2009-02-03 PlS Planned sale LUNDEMOSE ANKER MD, PH.D, DSC

Exec. VP & Pres. OSI Prosidion

Officer
2,000 -6.8%
41.25
US$82,500 		2,000 -6.8% 41.25 US$82,500
2009-02-05 2009-02-03 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
3,401 -9.0%
41.25
US$140,291 		3,401 -9.0% 41.25 US$140,291
2009-02-05 2009-02-03 PlS Planned sale GRANNER DARYL K Non-Executive Director
10,000 -37.7%
42.10
US$420,954 		10,000 -37.7% 42.10 US$420,954
2009-01-07 2009-01-06 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
49 -0.1%
40.00
US$1,960 		49 -0.1% 40.00 US$1,960
2008-11-21 2008-11-19 S Sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
10,000 -23.1%
39.11
US$391,100 		10,000 -23.1% 39.11 US$391,100
2008-11-12 2008-11-11 S Sale LUNDEMOSE ANKER MD, PH.D, DSC

Exec. VP & Pres. OSI Prosidion

Officer
3,500 -14.0%
39.53
US$138,355 		3,500 -14.0% 39.53 US$138,355
2008-11-12 2008-11-07 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
1,150 -4.4%
41.59
US$47,828 		1,150 -4.4% 41.59 US$47,828
2008-10-02 2008-10-01 PlS Planned sale GRANNER DARYL K Non-Executive Director
2,500 -13.1%
48.70
US$121,750 		2,500 -13.1% 48.70 US$121,750
2008-10-02 2008-10-01 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
1,150 -3.6%
48.70
US$56,005 		1,150 -3.6% 48.70 US$56,005
2008-09-16 2008-09-15 PlS Planned sale WHITE JOHN P Non-Executive Director
1,750 -7.9%
49.57
US$86,748 		1,750 -7.9% 49.57 US$86,748
2008-09-04 2008-09-02 PlS Planned sale GRANNER DARYL K Non-Executive Director
3,750 -18.5%
50.42
US$189,075 		3,750 -18.5% 50.42 US$189,075
2008-09-04 2008-09-02 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
1,150 -3.7%
50.42
US$57,983 		1,150 -3.7% 50.42 US$57,983
2008-08-19 2008-08-15 PlS Planned sale WHITE JOHN P Non-Executive Director
750 -3.4%
52.83
US$39,622 		750 -3.4% 52.83 US$39,622
Explore more

More insider trading research around OSI Pharmaceuticals LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America